Marshall Wace, LLP Uni Qure N.V. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Uni Qure N.V. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,125,656 shares of QURE stock, worth $19.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,125,656

Previous 39,078 2780.54%

Holding current value

$19.1 Million

Previous $175,000 3070.86%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $4.11 Million - $11 Million	1,086,578 Added 2780.54%	1,125,656 $5.55 Million
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $171,552 - $212,193	39,078 New	39,078 $175,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $143,238 - $252,535	21,347 New	21,347 $143,000
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $354,252 - $437,038	18,944 New	18,944 $381,000
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $6.49 Million - $10.1 Million	493,179 Added 671.3%	566,645 $10.6 Million
Q2 2021 Aug 13, 2021	BUY	$29.97 - $37.17 $2.2 Million - $2.73 Million	73,466 New	73,466 $2.26 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $20.5 Million - $29.5 Million	-701,084 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $29.6 Million - $42.4 Million	-836,821 Reduced 54.41%	701,084 $25.3 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $26.6 Million - $35.2 Million	737,928 Added 92.24%	1,537,905 $56.6 Million
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $35.3 Million - $53.1 Million	783,344 Added 4709.58%	799,977 $36 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $494,563 - $914,343	-12,361 Reduced 42.63%	16,633 $789,000
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $14 Million - $28.1 Million	-376,974 Reduced 92.86%	28,994 $2.08 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $10.5 Million - $20.5 Million	266,995 Added 192.12%	405,968 $16 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $7.33 Million - $11.4 Million	138,973 New	138,973 $10.9 Million
Q1 2019 May 14, 2019	SELL	$27.39 - $68.41 $94,742 - $236,630	-3,459 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $78,865 - $117,363	3,459 New	3,459 $100,000

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $793M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Uni Qure N.V. Transaction History